Arsenic induced inhibition of δ-aminolevulinate dehydratase activity in rat blood and its response to meso 2,3-dimercaptosuccinic acid and monoisoamyl DMSA

Biomedical and Environmental Sciences

Volumn 17, Issue 1, 2004, Pages 101-108

  Bhadauria, Smrati ^a,b   Flora, Swaran J S ^a  

^a Div of Pharmacology and Toxicology   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

aminolevulinic acid dehydratase; Arsenic toxicity; Chelation; Combined effects; DMSA and MiADMSA; In vivo and in vitro effects

Indexed keywords

ARSENIC; PORPHOBILINOGEN SYNTHASE; SUCCIMER;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENT; IN VITRO STUDY; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ANIMALS; ARSENIC POISONING; ARSENICALS; ENZYME INHIBITORS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; PORPHOBILINOGEN SYNTHASE; RATS; SUCCIMER;

ANIMALIA;

EID: 2442436802     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Goering, P. L. Aposhian, H. V., Mass, M. J., Cebrian, M., Beck, B. D., and Waalkes, M. P. (1999). The enigma of arsenic carcinogenesis: Role of metabolism. Toxicol. Sci. 49, 5-14.
2. Hindmarsh, J. T. (2000). Arsenic, its clinical and environmental significance. J. Trace Elem. Exp. Med. 13, 165-172.
3. Nemeti, B. and Gregus, Z. (2002). Reduction of an arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70, 4-12.
4. Silbergeld, E. K. and Fowler, B. A. (Eds) (1987). Mechanisms of chemical-induced porphyrinopathies. Ann. NY Acad. Sci. 514, 1-350.
5. Moore, M. R., McColl, K. E. L., Rimington, C., and Goldberg, A. (1987). Disorders of porphyrins metabolism Plenum Press, New York.
6. Bergdahl, I. A., Grubb, A., Schultz, A., Desnick, R. J., Wetmur, J. G., Sassa, S., and Skerfying, S. (1997). Lead binding to δ-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol. Toxicol. 81, 153-158.
7. Flora, S. J. S. (1999). Arsenic induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin. Exp. Pharmacol. Physiol. 26, 865-869.
8. Li, D., Morimoto, K., Takeshita, T., and Lu, Y. (2001). Arsenic induces DNA damage via reactive oxygen species in human cells. Environ. Health Prevent. Med. 6, 27-32.
9. Chen, Y. C., Lin-Shiau, S. Y., and Lin, J. K. (1998). Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell Physiol. 177, 324-329.
10. Flora, S. J. S., Bhattacharya, R., and Vijayaraghavan, R. (1995). Combined therapeutic potential of meso 2,3-dimercaptosuccinic acid and calcium disodium edetate in the mobilization and distribution of lead in experimental lead intoxication in rats. Fund. Appl. Toxicol. 25, 233-240.
11. Aposhian, H. V. and Aposhian, M. M. (1989). Newer developments in arsenic toxicity. J. Am. Coll. Toxicol. 8, 1297-1305.
12. Kreppel, H., Pepcke, U., Thierman, H., Szinicz, L., Reichl, F. X., and Singh, P. K. (1993). Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxide poisoning in mice. Arch. Toxicol. 67, 580-585.
13. Aposhian, H. V. and Aposhian, M. M. (1990). Meso 2,3-dimercaptosuccinic acid, chemical, pharmacological and toxicological properties of an orally effective metal chelating agents. Ann. Rev. Pharmacol. Toxicol. 30, 279-306.
14. Jones, M. M., Singh, P. K., Gale, G. R., Smith, A. B., and Atkins, L. (1992). Cadmium mobilization in vivo by intraperitoneal or oral administration of monoalkyl esters of meso 2,3-dimercaptosuccinic acid in the mouse. Pharmacol. Toxicol. 70, 336-343.
15. Xu, C., Holscher, M. A., Jones, M. M., and Singh, P. K. (1995). Effect of monoisoamyl meso 2,3-dimercaptosuccinate on the pathology of acute cadmium intoxication. J. Toxicol. Environ. Health 45, 261-277.
16. Flora, S. J. S., Kannan, G. M., Pant, B. P., and Jaiswal, D. K. (2002). Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats. Arch. Toxicol. 76, 269-276.
17. Flora, S. J. S., Dubey, R., Kannan, G. M., Chauhan, R. S., Pant, B. P., and Jaiswal, D. K. (2002). Meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA effect on gallium arsenide induced pathological liver injury in rats. Toxicol. Lett. 132, 9-17.
18. Flora, S. J. S., Kannan, G. M., Pant, B. P., and Jaiswal, D. K. (2003). The Efficacy of Monoisoamyl Ester of Dimercaptosuccinic Acid in Chronic Experimental Arsenic Poisoning in Mice. J. Environ. Sci. Health (Part C) 38, 241-254.
19. Berlin, A. and Schaller, K. H. (1974). European standardized method for the determination of delta aminolevulinic dehydratase in blood. Z. Klin. Chem. Klin. Biochem. 12, 389-390.
20. Emanuelli, T., Rocha, J. B. T., Perira, M. E., Nascimento, P. C., Souza, D. O. Z., and Beber, A. (1998). δ-aminolevulinate dehydratase inhibition by 2,3-dimercaptopropanol is mediated by chelation of zinc from a site involved in maintaining cysteinyl residue in a residue in a reduced state. Pharmacol. Toxicol. 83, 95-103.
21. Thomas, D. J., Styblo, M., and Lin, S. (2001). The cellular metabolism and systemic toxicity of arsenic. Toxicol. App. Pharmacol. 176, 127-144.
22. Kannan, G. M., Tripathi, N., Dube, S. N., Gupta, M., and Flora, S. J. S. (2001). Toxic effects of arsenic (III) on some hematopoietic and central nervous system variables in rats and guinea pigs. Clin. Toxicol. 39, 675-682.
23. Beber, F. A., Wollmester, M. J. K., Brigo, M. C., Silva, J., Pereira, C. N., and Rocha, J. B. T. (1998). δ-aminolevulinate dehydratase inhibition by ascorbic acid is mediated by an oxidation system existing in the hepatic supernatant. Internat. J. Vit. Nutr. Res. 68, 181-188.
24. Ercal, N., Treeratphan, P., Hammond, T. C., Matthews, R. H., Grannemann, N., and Spitz, D. (1996). In vivo indices of oxidative stress in lead exposed c57b1/6 mice are reduced by treatment with meso 2,3-dimercaptosuccinic acid or n-acetylcysteine. Free Radic. Biol. Med. 21, 157-161.
25. Rivera, M., Levine, D. J., Aposhian, H. V., and Fernando, Q. (1991). Synthesis and properties of monomethyl ester of meso dimercaptosuccinic acid and its chelators of lead (II), cadmium (II) and mercury (II). Chem. Res. Toxicol. 4, 107-114.
26. Walker, E. M., Stone, A., Milligan, L. B., Gale, G. R., Atkins, L. M., Smith, A. B., Jones, M. M., Singh, P. K., and Basinger, B. A. (1992). Mobilization of lead in mice by administration of monoalkyl esters of meso-2,3-dimiercaptosuccinic acid. Toxicol. 76, 79-87.
27. Mehta, A. and Flora, S. J. S. (2001). Chelating Agents induced Hepatic and Renal Biochemical Alterations and Metallothionein Induction in Rats. Fd. Chem. Toxicol. 39, 1029-1038.
28. Flora, S. J. S. (2002). Nutritional components modify metal absorption, toxic response and chelation therapy. J. Nutri. Environ. Med. 12, 51-65.
29. Pande, M., Mehta, A., Pant, B. P., and Flora, S. J. S. (2001). Combined administration of a chelating agent and an antioxidant in the prevention and treatment of acute lead intoxication in rats. Environ. Toxicol. Pharmacol. 9, 173-184.
30. Flora, S. J. S. and Kumar, P. (1996). Biochemical and immunotoxicological alterations following repeated gallium arsenide exposure and their recoveries by meso 2,3-dimercaptosuccinic acid and 2,3-dimercaptopropane 1-sulfonate administration in rats. Environ. Toxicol. Pharmacol. 2, 315-320.